Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease atrial fibrillation
Comorbidity C0011847|diabetes
Sentences 24
PubMedID- 21747831 Therefore, atrial fibrillation pattern in patients with diabetes should be regarded as a prognostic marker of adverse outcome and prompt aggressive management of all risk factors is required [30].
PubMedID- 26476086 Background: there are no proven strategies to prevent atrial fibrillation (af) in patients with type 2 diabetes (t2dm).
PubMedID- 20405332 Objective: to examine the association of diabetes with risk of atrial fibrillation and to describe risk according to diabetes duration and glycemic control.
PubMedID- 23990675 Older age, female sex, african american race and hispanic ethnicity, unemployed status, diabetes, hypertension, history of stroke, and permanent atrial fibrillation were positively associated with ischemic stroke, whereas body mass index >30 kg/m(2) was inversely associated with stroke (p<0.001 for each).
PubMedID- 21985750 Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the proactive study.
PubMedID- 22981550 Type 2 diabetes mellitus and risk of incident atrial fibrillation in women.
PubMedID- 20822544 The variables used in the framingham risk score are age, systolic blood pressure, antihypertensive therapy, diabetes mellitus, smoking, history of cvd, atrial fibrillation, and lvh.
PubMedID- 21094363 Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose.
PubMedID- 24699792 atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy.
PubMedID- 26254188 Aim: diabetes has been associated with atrial fibrillation but the current evidence is conflicting.
PubMedID- 25159234 atrial fibrillation (af) is prevalent in patients with type 2 diabetes mellitus (dm) and is associated with markers of poor glycemic control; however, the impact of glycemic control on incident af and outcomes is unknown.
PubMedID- 20937975 No clinical parameters such as age, hypertension, diabetes mellitus, previous history of stroke, type of atrial fibrillation, and preablation antithrombotic treatment showed significant correlation with ischemic cerebral embolism.
PubMedID- 25082849 Aims: we investigated whether glucose fluctuations aggravate cardiac fibrosis and increase the occurrence of atrial fibrillation (af) in rats with diabetes mellitus (dm).
PubMedID- 23273718 Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.
PubMedID- 26064216 Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus.
PubMedID- PMC4125833 The study is expected to give detailed information on the increased prevalence of atrial fibrillation in patients with type 2 diabetes and provides the data base for an optimized therapy regime in order to avoid cardio-vascular complications.
PubMedID- 26498716 Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.
PubMedID- 25192283 Methods: in this prospective cohort study, 2,144 hong kong chinese with type 2 diabetes and without history of stroke or atrial fibrillation were recruited in 1994-1996 and followed up for a median of 14.51 years.
PubMedID- 23576900 Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus.
PubMedID- 20659042 [atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy].
PubMedID- 23672990 Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
PubMedID- 25827533 Nine predictors (coronary artery disease, diabetes mellitus, hypertension, history of cerebrovascular disease, atrial fibrillation, smoking, the findings of carotid doppler ultrasonography [normal, plaque, plaque+stenosis>/=50%], the levels of cholesterol and c-reactive protein) were used for predicting the stroke.
PubMedID- 20550690 The risk factors were presented in the questionnaire in the following order: higher age, hyperlipidemia, diabetes, a family history of cardiovascular disease, atrial fibrillation, hypertension, overweight, regular physical exercise, excessive alcohol consumption, previous stroke/tia, carotid stenosis, smoking and ischaemic heart disease.
PubMedID- 26353872 Risk factors included age, body mass index (bmi), systolic blood pressure, cholesterol/ high-density lipoprotein (hdl) ratio, glycosylated haemoglobin (hba1c), material deprivation, ethnicity, smoking, diabetes duration, type of diabetes, atrial fibrillation, cardiovascular disease, chronic renal disease, and family history of premature coronary heart disease.

Page: 1